Please use this identifier to cite or link to this item:
Title: Dengue serotype cross-reactive, anti-E protein antibodies confound specific immune memory for 1 year after infection
Authors: Toh, Y.X
Gan, V
Balakrishnan, T
Zuest, R
Poidinger, M 
Wilson, S
Appanna, R
Thein, T.L
Ong, A.K.-Y
Ng, L.C
Leo, Y.S 
Fink, K
Issue Date: 2014
Citation: Toh, Y.X, Gan, V, Balakrishnan, T, Zuest, R, Poidinger, M, Wilson, S, Appanna, R, Thein, T.L, Ong, A.K.-Y, Ng, L.C, Leo, Y.S, Fink, K (2014). Dengue serotype cross-reactive, anti-E protein antibodies confound specific immune memory for 1 year after infection. Frontiers in Immunology 5 (AUG) : Article 388. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Dengue virus has four serotypes and is endemic globally in tropical countries. Neither a specific treatment nor an approved vaccine is available, and correlates of protection are not established. The standard neutralization assay cannot differentiate between serotype-specific and serotype cross-reactive antibodies in patients early after infection, leading to an overestimation of the long-term serotype-specific protection of an antibody response. It is known that the cross-reactive response in patients is temporary but few studies have assessed kinetics and potential changes in serum antibody specificity over time. To better define the specificity of polyclonal antibodies during disease and after recovery, longitudinal samples from patients with primary or secondary DENV-2 infection were collected over a period of 1 year. We found that serotype cross-reactive antibodies peaked 3 weeks after infection and subsided within 1 year. Since secondary patients rapidly produced antibodies specific for the virus envelope (E) protein, an E-specific ELISA was superior compared to a virus particle-specific ELISA to identify patients with secondary infections. Dengue infection triggered a massive activation and mobilization of both naïve and memory B cells possibly from lymphoid organs into the blood, providing an explanation for the surge of circulating plasmablasts and the increase in cross-reactive E protein-specific antibodies. © 2014 Toh, Gan, Balakrishnan, Zuest, Poidinger, Wilson, Appanna, Thein, Ong, Ng, Leo and Fink.
Source Title: Frontiers in Immunology
ISSN: 16643224
DOI: 10.3389/fimmu.2014.00388
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fimmu_2014_00388.pdf3.01 MBAdobe PDF




checked on Sep 21, 2022

Page view(s)

checked on Sep 22, 2022

Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons